Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hachimijiogan, a traditional herbal medicine, modulates adipose cell function and ameliorates diet-induced obesity and insulin resistance in mice.
Kagawa S, Tanabe K, Hiromura M, Ogawa K, Koga T, Maeda T, Amo-Shiinoki K, Ochi H, Ichiki Y, Fukuyama S, Suzuki S, Suizu N, Ohmine T, Hamachi S, Tsuneki H, Okuya S, Sasaoka T, Tanizawa Y, Nagashima F. Kagawa S, et al. Among authors: hiromura m. Front Pharmacol. 2023 May 12;14:1167934. doi: 10.3389/fphar.2023.1167934. eCollection 2023. Front Pharmacol. 2023. PMID: 37251332 Free PMC article.
Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Takehana N, Fukui T, Mori Y, Hiromura M, Terasaki M, Ohara M, Takada M, Tomoyasu M, Ito Y, Kobayashi T, Yamagishi SI. Takehana N, et al. Among authors: hiromura m. J Diabetes Investig. 2023 Jul;14(7):856-863. doi: 10.1111/jdi.14016. Epub 2023 Apr 20. J Diabetes Investig. 2023. PMID: 37082800 Free PMC article.
Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
Fukui T, Takehana N, Mori Y, Hiromura M, Terasaki M, Kushima H, Takada M, Tomoyasu M, Sato N, Hayashi T, Ohara M, Kikuchi T, Ito Y, Kobayashi T, Yamagishi SI. Fukui T, et al. Among authors: hiromura m. Endocr J. 2022 Nov 28;69(11):1343-1349. doi: 10.1507/endocrj.EJ22-0146. Epub 2022 Jun 24. Endocr J. 2022. PMID: 35753761 Free article.
Author Correction: The cardiac molecular setting of metabolic syndrome in pigs reveals disease susceptibility and suggests mechanisms that exacerbate COVID-19 outcomes in patients.
Ziegler O, Sriram N, Gelev V, Radeva D, Todorov K, Feng J, Sellke FW, Robson SC, Hiromura M, Alexandrov BS, Usheva A. Ziegler O, et al. Among authors: hiromura m. Sci Rep. 2021 Oct 28;11(1):21613. doi: 10.1038/s41598-021-00995-z. Sci Rep. 2021. PMID: 34711865 Free PMC article. No abstract available.
Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study.
Ohara M, Nagaike H, Fujikawa T, Kohata Y, Ogawa M, Omachi T, Sasajima R, Chiba H, Ara T, Sugawara A, Hiromura M, Terasaki M, Mori Y, Fukui T, Hirano T, Yokoyama H, Yamagishi SI. Ohara M, et al. Among authors: hiromura m. Diabetes Res Clin Pract. 2021 Sep;179:108999. doi: 10.1016/j.diabres.2021.108999. Epub 2021 Aug 12. Diabetes Res Clin Pract. 2021. PMID: 34390762 Clinical Trial.
66 results